Fragile X syndrome (FXS) results from the loss of the fragile X mental retardation protein (FMRP), an RNA-binding protein that regulates a variety of cytoplasmic mRNAs. FMRP regulates mRNA translation and may be important in mRNA localization to dendrites. We report a third cytoplasmic regulatory function for FMRP: control of mRNA stability. In mice, we found that FMRP binds, in vivo, the mRNA encoding PSD-95, a key molecule that regulates neuronal synaptic signaling and learning. This interaction occurs through the 3¢ untranslated region of the PSD-95 (also known as Dlg4) mRNA, increasing message stability. Moreover, stabilization is further increased by mGluR activation. Although we also found that the PSD-95 mRNA is synaptically localized in vivo, localization occurs independently of FMRP. Through our functional analysis of this FMRP target we provide evidence that dysregulation of mRNA stability may contribute to the cognitive impairments in individuals with FXS.
Fragile X syndrome (FXS) results from the loss of the fragile X mental retardation protein (FMRP), an RNA-binding protein that regulates a variety of cytoplasmic mRNAs. FMRP regulates mRNA translation and may be important in mRNA localization to dendrites. We report a third cytoplasmic regulatory function for FMRP: control of mRNA stability. In mice, we found that FMRP binds, in vivo, the mRNA encoding PSD-95, a key molecule that regulates neuronal synaptic signaling and learning. This interaction occurs through the 3¢ untranslated region of the PSD-95 (also known as Dlg4) mRNA, increasing message stability. Moreover, stabilization is further increased by mGluR activation. Although we also found that the PSD-95 mRNA is synaptically localized in vivo, localization occurs independently of FMRP. Through our functional analysis of this FMRP target we provide evidence that dysregulation of mRNA stability may contribute to the cognitive impairments in individuals with FXS.
FXS is caused by a trinucleotide expansion in the X-linked fragile X mental retardation gene (FMR1) that leads to the subsequent loss of FMRP, and it is the most common cause of X-linked mental retardation. FMRP has multiple RNA-binding motifs and is thought to be involved in mRNA localization and translational regulation in neurons, two processes required for synaptic plasticity (reviewed in ref. 1) . Because the only obvious abnormality in the brains of individuals with FXS is the presence of longer, immature-appearing spines 1 , current models have focused on the possible dysregulation of synaptic mRNAs as an underlying cause of FXS mental deficits.
A wide variety of mRNAs have been identified as potential targets of mammalian FMRP, both in vitro and in vivo 2, 3 . FMRP binds various mRNA elements 1 , including a G-rich RNA structure (G-quartet) [4] [5] [6] and U-rich stretches 7 . FMRP is also indirectly recruited to some target mRNAs via binding to the noncoding RNAs BC1 and BC200 (refs. [8] [9] [10] [11] . Finally, both mammalian and Drosophila FMRP are present in microRNA (miRNA) complexes 12 and may be recruited to mRNAs that are bound to miRNAs.
In the FMRP protein, the RGG box recognizes G-quartet sequences present in some FMRP targets 4 , whereas the N-terminus recognizes a bulge in BC RNAs 10 . Notably, although FMRP contains two KH domains, a known RNA-binding motif, no endogenous neuronal targets that are recognized by this domain have been identified 13 . Functionally, FMRP acts as a translational repressor of a subset of neuronal mRNAs 3 , and it may be involved in synaptic mRNA localization, as FMRP is present in mRNP localization complexes 14 .
A limited number of studies also suggest that FMRP may regulate transcription [15] [16] [17] .
Despite much research, it remains unclear precisely how the loss of FMRP leads to alterations in the neuronal mechanisms responsible for cognition. One proposal suggests that alterations in metabotropic glutamate receptor (mGluR)-mediated signaling might underlie a number of the cognitive deficits associated with FXS 18 . Disruption of NMDA receptors 19 or associated signaling components [20] [21] [22] can also lead to impairments in synaptic plasticity. Notably, mGluRs and NMDA receptors coexist in a large-scale signaling complex 23 . PSD-95 (DLG4), a component of the MAGUK family of adaptor proteins that includes SAP102 (DLG3) and PSD-93, binds directly to the NMDA receptor and links other adaptors to mGluRs 24 . Mice lacking PSD-95 have impairments in learning 20 and cortical plasticity 21 . Similarly, SAP102 mutant mice show learning impairments 25 , and mutations in human SAP102 are implicated in mental retardation 26 . Notably, PSD-95 mutant mice also show dendritic spine abnormalities in the striatum and hippocampus 27 , one of the key alterations seen in humans with FXS and in FMRP mutant mice 1 . A quantitative neuroimaging study also found larger right and left hippocampal volumes in individuals with FXS compared with controls, suggesting that this region may be involved in the behavioral and cognitive abnormalities associated with FXS 28 .
One report has indicated that FMRP regulates PSD-95 protein levels in response to mGluR signaling 29 . However, putative FMRP-binding sites were identified by sequence analysis, and direct interactions between the PSD-95 mRNA and FMRP were not tested. Although the authors concluded that these effects were due to translational regulation of PSD-95 mRNA, the above mentioned results could not formally distinguish between effects on mRNA export, stability or translation.
In this study we provide a detailed assessment of the role that FMRP has in controlling PSD-95 expression. We have found that FMRP interacts directly with the 3¢ UTR of the PSD-95 mRNA, providing evidence that FMRP is important in increasing the stability of the PSD-95 message. This stabilization is further increased by mGluR activation. These findings suggest that, in addition to dysregulation of translation targets, some of the FXS impairments may arise as a result of alterations in the stability of FMRP target mRNAs.
RESULTS

PSD-95 mRNA interacts directly with FMRP
To address whether FMRP directly regulates PSD-95 mRNA, we examined whether PSD-95 mRNA was present in the FMRP complex in mice. We found PSD-95 mRNA in FMRP immunoprecipitates from wild-type mice but not from FMR1 knockout mice (Fig. 1a) . A known FMRP-interacting mRNA, MAP1B (refs. 8, 30, 31) , was also coprecipitated (Fig. 1a) , whereas a negative control mRNA (GluR1, also known as Gria1) was not (Fig. 1a) . Using reversible cross-linking-immunoprecipitation (CLIP) 32 from primary hippocampal neurons (Fig. 1b) , we showed that FMRP bound directly to the PSD-95 mRNA, as crosslinking occurred only if FMRP and PSD-95 were in close proximity in vivo. MAP1B mRNA, but not GlyRa (also called Glra1) mRNA, was also cross-linked to FMRP (Fig. 1b) .These data indicate that PSD-95 mRNA is part of the FMRP mRNP complex in vivo.
To map the FMRP-PSD-95 mRNA interaction, we carried out direct protein-RNA binding assays. We focused on the 3¢ untranslated region (UTR) of PSD-95 mRNA because in silico analysis of this region had shown the presence of a putative G-quartet 29 and three U-rich stretches 33 ( Fig. 1c and Supplementary Fig. 1 online) , sequence elements previously shown to recruit FMRP to RNAs 4, 7 . Of the five short RNAs that spanned the entire 3¢ UTR of the mouse PSD-95 mRNA (Fig. 1c) , only fragment 5 had FMRP-binding ability in electrophoretic mobility shift assays (EMSAs) with purified baculovirus-expressed human FMRP protein (Fig. 1d) . This RNA fragment was also bound by mouse brain extracts (data not shown). The lack of FMRP binding to fragments 1-4 ( Fig. 1d) and the antisense strand (data not shown), and the ability of excess unlabeled fragment 5 RNA to compete, indicated that the FMRP-RNA interaction was specific and did not simply reflect general RNA affinity. The protein-binding ability of fragment 5 RNA was also specific, as it did not bind other RNA binding proteins (the microbial transcription and translation modulator NusG or the spliceosomal 15.5-kDa (hSnu13p) protein; data not shown).
We also investigated which protein domain of FMRP (N-terminus, KH1, KH2 or C-terminus) 34 was involved in binding to the PSD-95 mRNA (Fig. 2a) . We found that only the C-terminus contained PSD-95 mRNA-binding ability (Fig. 2b) . This domain bound with high affinity, as binding remained present under high-stringency conditions (50 mM LiCl) (Fig. 2c) . The binding was specific, as the C-terminus did not interact with fragment 1, and binding to fragment 5 was competed with by excess unlabeled fragment 5, but not fragment 1 (Fig. 2c) .
We further mapped the mRNA region in fragment 5 that was responsible for FMRP binding by scrambling the G-rich region to eliminate all similarity to the G-quartet consensus and converting the U-rich regions into mixed sequences (Fig. 3a) . High lithium (50 mM), a condition that destabilizes G-quartet structures 4, 35 , did not interfere with FMRP binding to either the wild-type (Fig. 3b) or the mutagenized fragment 5 (Fig. 3b) . Notably, mutagenesis of all three U-rich regions did not prevent FMRP binding (Fig. 3b) . Because previous studies suggested that FMRP has a high affinity for poly(rG) in vitro 34 , we further examined the G-rich region.
Although the entire G-rich region showed binding to FMRP (Figs. 3c,d ; I + II G-rich), even in the presence of high lithium salt (Fig. 3d) , no binding was detected when we used two short RNA fragments (Figs. 3c,d ) of that region (Fig. 3c) . Our findings argue that FMRP recognizes a structured G-rich sequence in the 3¢ UTR of the PSD-95 mRNA or a region spanning the two fragments, and that this structure does not form a G-quartet.
Similar PSD-95 polysomal profile in wild type and knockout FMRP can act as a translational repressor 3, 31 and local translation of synaptic mRNAs has been increasingly implicated in neuronal plasticity, learning and memory formation (reviewed in ref. 36) . Notably, a number of localized mRNAs encode synaptic proteins (for example, Arc, MAP1B, aCaMKII and SAPAP4) that are translationally repressed by FMRP 8, 16 . Thus far, our experiments indicate that FMRP can directly interact with the PSD-95 mRNA, but do not address the functional role of this interaction.
We assessed whether PSD-95 mRNA translation was regulated by FMRP, as was previously proposed 29 , by carrying out sucrose gradient fractionation of cytoplasmic (Fig. 4a) and hippocampal ( Fig. 4b) brain extracts from wild-type and FMR1 knockout mice. Unexpectedly, the percentage of PSD-95 mRNA associated with polysomes did not change in the FMR1 knockout animals compared with wild-type animals in either whole brain or hippocampal extracts. Although the profile of the negative control, b-actin (ACTB) mRNA, also remained unchanged, Arc mRNA, which is known to be translationally regulated by FMRP 8 , showed the expected shift toward a more translationally active polysome pool in FMR1 knockout extracts. We cannot formally rule out the possibility that FMRP changes the translation efficiency of the PSD-95 mRNA without changing the percentage messenger on polysomes (PMP) ratio (for example, by altering miRNA-regulated translation; reviewed in ref. 37 ). However, because other FMRPregulated mRNAs (such as Arc) do change their PMP ratio, the above findings indicate that FMRP does not regulate PSD-95 protein synthesis in a manner similar to those of other well-studied FMRP targets.
PSD-95 mRNA is dendritically localized with FMRP in vivo
It has been estimated that hundreds of mRNAs are present in dendrites, but whether the entire population or only a subset are localized near synapses is currently unknown 38 . Because this list includes mRNAs that are known targets of FMRP (for example, Arc, aCaMKII), and because PSD-95 is an integral component of the postsynaptic density, we assessed whether the PSD-95 message was localized in dendrites and, if so, whether this localization was dependent on FMRP.
By analyzing the presence of PSD-95 mRNA in synaptoneurosomes from total brain, we found that PSD-95 mRNA showed a marked dendrite/soma enrichment ratio ( Supplementary Fig. 2 online), suggesting that the mRNA was localized at synapses. This was further confirmed by in situ hybridization in neuronal cultures (Fig. 5) . We found that PSD-95 mRNA localized in both cell bodies and along dendrites of hippocampal ( Fig. 5a ) and cortical (data not shown) neurons with a typical punctate pattern. Similarly, a recent large-scale screen also suggested putative targeting of the PSD-95 mRNA to both proximal and distal dendrites 39 . Unexpectedly, although PSD-95 mRNA largely colocalized with FMRP throughout the cell and into neurites (Fig. 5a) , the PSD-95 mRNA was still localized in dendrites from FMR1 knockout hippocampal ( Fig. 5a ) and cortical (data not shown) cultures. Control experiments indicated that we could specifically detect dendritic (aCaMKII) and cell body (a-tubulin) mRNAs 38 ( Fig. 5b) , and that the sense probes did not show any specific mRNA staining ( Supplementary Fig. 3 online). These data further confirm that the PSD-95 message is part of an FMRP mRNP complex, but suggest that FMRP function is not necessary to localize the PSD-95 message.
We confirmed that PSD-95 mRNA was dendritically localized using both digoxigenin (DIG) RNA labeling (data not shown) and radioactive in situ hybridization (Fig. 6 ) on brain slices. PSD-95 mRNA was present in the hippocampus, cortex (Fig. 6a) and cerebellum (Fig. 6b) . The unlocalized control mRNA (a-tubulin) stained only cell bodies in the hippocampus and dentate gyrus ( Fig. 6c and Supplementary Fig. 4 online). Although PSD-95 mRNA localization was distinct from another localized mRNA (aCaMKII; Fig. 6d and Supplementary  Fig. 4 ), PSD-95 mRNA was clearly present in hippocampal dendrites of both wild-type and FMR1 knockout mice in a region corresponding RNA-protein complexes were resolved on a native polyacrylamide gel. Unbound RNA fragments (') and RNA-protein complexes (*) are indicated.
to the stratum lacunosum-moleculare ( Fig. 6a and Supplementary  Fig. 4) . A control PSD-95 mRNA sense probe did not show any specific mRNA staining ( Supplementary Fig. 3) . Notably, quantification of PSD-95 mRNA levels showed a clear, though nonsignificant, reduction in hippocampal mRNA in the FMR1 knockout animals relative to cortical mRNA levels ( Fig. 6a, P 4 0.05). This tendency was not observed when comparing PSD-95 cerebellar with cortical mRNA (Fig. 6b) or a-tubulin hippocampal with cortical mRNA (Fig. 6c) ratios between wild-type and FMR1 knockout mice.
Together, these data provide evidence that the PSD-95 mRNA is localized in dendrites in vitro and in vivo. As there is less PSD-95 mRNA in the stratum lacunosum-moleculare in FMR1 knockout mice (Fig. 6a) , we cannot exclude the possibility that FMRP might be involved in a subtle modulation of PSD-95 mRNA localization. However, as PSD-95 mRNA is clearly present in dendrites in the absence of FMRP (Figs. 5a and 6a) , our data suggest that the FMRP does not have a primary role in PSD-95 mRNA localization.
Impaired PSD-95 mRNA and protein levels in FMR1 knockout Our results suggest that FMRP does not directly regulate translation (Fig. 4) or transport (Figs. 5 and 6) of PSD-95 mRNA. Earlier reports, however, have suggested that FMRP might also control mRNA abundance via transcriptional regulation [15] [16] [17] . Notably, our radioactive in situ hybridization data indicated a possible decrease in PSD-95 mRNA intensity in hippocampal neurons from FMR1 knockout mice (Fig. 6a) , suggesting that mRNA abundance may be regulated by FMRP.
To determine whether FMRP controls mRNA abundance, we first examined the total PSD-95 mRNA level in wild-type and FMR1 knockout mice. In total brain, PSD-95 mRNA levels were significantly decreased in FMR1 knockouts compared with wild-type mice (Fig. 7a) . Notably, quantitative RT-PCR analyses carried out on the three principal brain areas (hippocampus, cerebellum and cortex) showed that the decrease in PSD-95 mRNA was very pronounced in the hippocampus, less so in the cerebellum and not observed in the cortex (Fig. 7b) . Quantitative RT-PCR analyses of the PSD-95 mRNA from hippocampal neurons of wild-type and FMR1 knockout mice confirmed this hippocampal-specific decrease in PSD-95 mRNA (Fig. 7c) . Although there was a subtle trend toward lower abundance of PSD-95 mRNA in the hippocampus as detected with radioactive in situ hybridization (Fig. 6) , this was not statistically significant, and we believe that these differences may be due to different sensitivities of the techniques. Differential PSD-95 expression was also reflected at the protein level, with a statistically significant decrease occurring in the hippocampus and a nonsignificant decrease in the cerebellum (Fig. 7d, P 4 0.05) .
These data suggest that either transcription or stability of the PSD-95 mRNA is regulated by FMRP in the hippocampus. Critically, the hippocampus is important for the learning processes that are altered in people with FXS 40 , and the loss of PSD-95 results in hippocampaldependent learning defects 20 .
Activity-dependent FMRP control of PSD-95 mRNA stability To directly assess whether this change in mRNA level was a result of altered transcription or mRNA stability, we examined the half-life of the PSD-95 message in cortical and hippocampal primary cultured neurons. Notably, after transcriptional blockade with actinomycin D, PSD-95 mRNA abundance was significantly and selectively reduced in hippocampal cultures in the absence of FMRP (Fig. 8a and Supplementary Fig. 5 online) . The stability of PSD-95 mRNA was unaffected in FMR1 knockout cortical cultures ( Supplementary Fig. 6 online), in agreement with prior results (Fig. 6a and 7b,c) . These results were not due to nonspecific cell death effects, as the morphology of hippocampal cells from wild-type and FMR1 knockout mice were the same (Supplementary Fig. 7 online) and cell survival was the same in both genotypes (Fig. 8b) , although we did note that after 12 h both the wildtype and FMR1 knockout neurons showed some increase in the amount of cell death (E25%). Together, these results suggest that FMRP functions to stabilize the PSD-95 mRNA specifically in the hippocampus. Furthermore, the stability of a reporter (Renilla reniformis luciferase) RNA carrying the FMRP-interacting portion of the PSD-95 3¢ UTR (fragment 5) was more stable when transfected into wild-type versus FMR1 knockout hippocampal neurons (Fig. 8c) , whereas a reporter RNA containing another PSD-95 3¢ UTR that does not bind FMRP (fragment 2) was equally unstable in both cultures (Fig. 8c) . These data strongly suggest that a direct interaction between FMRP and the PSD-95 3¢ UTR is necessary to confer mRNA stabilization. Because FMRP has not been previously shown to regulate mRNA stability, we also assessed the stability of 11 other FMRP targets and 2 synaptic scaffolding proteins whose mRNAs are localized in dendrites (Homer1a and Shank1). Of these mRNAs (Supplementary Table 1 online), only myelin basic protein mRNA (MBP) changed its stability. MBP mRNA is a target of FMRP regulation 41 , and is present only in glia cells, which also express FMRP 8, 41 . We detected the MBP mRNA because our primary neurons were cocultured with glial cells. Notably, although this list is clearly not exhaustive, our analyses suggest that FMRP-mediated mRNA stabilization is a highly selective mechanism with respect to both cell type and target mRNA, and that it works in both neurons and glia.
Because FMRP is regulated by mGluR activation (for example, see refs. 29,42,43), we also investigated whether mGluR stimulation would alter FMRP-dependent PSD-95 mRNA stabilization. Using two independent protocols (see Methods for details), we found that the presence of (S)-3,5-dihydroxyphenylglycine (DHPG) further stabilized PSD-95 mRNA in wild-type cells at both time points measured (Fig. 8d) . In FMR1 knockout cells, the addition of DHPG provided only transient stabilization that did not persist at the later time point, suggesting that DHPG might also have a transient, FMRP-independent effect on mRNA half-life. Quantification of three independent experiments indicated that there was a significant DHPG-dependent stabilization effect only in the wild-type neurons and that this effect was mostly lost in FMR1 knockout hippocampal cells (Fig. 8d) . Together, the data suggest that there is a long-lasting FMRP-dependent stabilization effect via mGluR-specific neuronal activity.
DISCUSSION
In this paper we have shown that FMRP interacts directly with the 3¢ UTR of PSD-95 mRNA. However, we found that PSD-95 mRNA polysomal association remained the same in wild-type and FMR1 knockout mice and that the PSD-95 mRNA was still dendritically localized in FMR1 knockout neurons. Although translation of the PSD-95 mRNA may decrease as a result of postinitiation mechanisms (that is, as in the case of some miRNAs; reviewed in ref. 37 ) that we cannot detect with the current assay, this translation mechanism would be different from that previously documented for other FMRP targets (such as Arc).
Notably, we found that the FMRP-PSD-95 mRNA interaction resulted in a stabilization of the PSD-95 message that can be further increased via mGluR stimulation. In FMR1 knockout mice the PSD-95 message was less stable, resulting in a reduction of this critical synaptic protein. These observations are consistent with previous circumstantial evidence suggesting that FMRP could potentially control mRNA abundance. A microarray study identified 113 FMRP-associated mRNAs whose abundances are reduced in fragile X cell lines, yet whose polysome profile remained unchanged 16 . Another study found decreases in the levels of some FMRP-target mRNAs in the absence of FMRP 17 . Although neither group examined these mRNAs further, it is possible that reduced levels of these mRNAs actually reflect a loss of mRNA stability in the absence of FMRP. Our finding that at least one other mRNA (MBP) was destabilized in the absence of FMRP lends support to this idea.
Unexpectedly, we found that the stabilization of the PSD-95 message was dependent on the area of the brain examined. The effect was most prominent in the hippocampus, present to a minor extent in cerebellum and nonexistent in the cortex. This lack of a cortical effect is consistent with previous findings that PSD-95 protein levels are the same in wild-type and FMR1 knockout cortical cells 29 . That study also observed an FMRP-dependent increase in PSD-95 protein in cortical cells shortly after DHPG treatment, but found that protein levels fell back to baseline by 4 h 29 , suggesting that there was a transient surge in PSD-95 expression. In hippocampal neurons, we observed that the relative level of the PSD-95 mRNA rose slightly after 4-6 h of DHPG exposure, suggesting that there is an additional activity-dependent increase in RNA stability. Together, these data suggest that FMRP can regulate, according to the physiological state (DHPG-treated or not) and cell type (cortical or hippocampal), both a rapid rise in PSD-95 translation (cortex) and a more prolonged rise in PSD-95 mRNA levels as a result of an increase in stability (hippocampus), and suggest that FMRP could have multiple independent roles.
We have mapped the binding site of FMRP to a G-rich element that is flanked by two AU-rich elements (AREs), well-known cis-acting mRNA elements that regulate mRNA half-life. Several trans-acting factors that aid in both stabilization and destabilization of target mRNAs are known to bind to AREs 44 . Notably, regulation of HuD, a member of the Hu class of ARE-binding proteins 44 , during neuronal development results in temporal regulation of GAP-43 (ref. 45) . Similarly, regulation of mRNA stability is often the result of competition between stabilizing and destabilizing factors 44 . It is therefore plausible that the region-specific regulation of the PSD-95 message is a result of interference between the stabilizing role of FMRP and the stabilizing and destabilizing functions of other binding factors. In support of this notion, we found that the hippocampus and cortex contained different forms of Hu-family proteins ( Supplementary  Fig. 8 online) . Combinatorial models are an emerging theme explaining RNA-protein binding specificity (reviewed in ref. 46, 47) , and in our case may explain why FMRP does not stabilize all of its known binding targets (Supplementary Table 1) .
We also found that the PSD-95 mRNA was localized in dendrites in vivo, but that its localization was not dependent on FMRP, further highlighting the complexity surrounding FMRP's many roles in the cytoplasm. Several factors are known to bind to FMRP and are presumed to aid it in these cytoplasmic regulatory functions. To date, however, only one of these interactions has been shown to aid FMRP function. Cooperative binding between FMRP and the BC1 RNA leads to the translational repression of a subset of mRNAs, and BC1 functions as a repressor of translational initiation in rabbit reticulocyte assays 3 . We expect further binding partners to collaborate with FMRP to aid translational repression, mRNP localization and this newly identified mRNA stabilization function.
Although a large number of putative FMRP target mRNAs have been isolated in the past 5 years, relatively few are known to be involved in regulating synapse structure and function. Our results strengthen the idea that FMRP function is extremely important for the correct formation of the postsynaptic compartment. These results also support the notion that the underlying cause of FXS, and potentially other forms of mental retardation, may involve direct interference with synaptic signaling that leads to spine dysmorphogenesis and ultimately to memory defects 1 . Notably, the mRNA encoding a PSD-95 associated protein, SAPAP4, has also been shown to be in a complex with FMRP 16 . In addition, PSD-95, SAPAP4, Arc and aCaMKII are all components of the large-scale NMDA receptor signaling complex that links NMDA receptors to the mGluR signaling pathway 23 49, 50) , suggesting that strict regulation of PSD-95 expression is required for proper brain function. PSD-95 is important in both behavioral memory and dendritic spine morphology 27 , both features of FXS. Together, these results suggest that FMRP may regulate NMDA and mGluR receptor signaling through several proteins, including PSD-95, and that the cognitive and anatomical defects in FXS may arise from the disruption of this complex.
METHODS
Animal treatment. Animal care conformed to institutional guidelines in compliance with national and international laws and policies (European Community Council Directive 86/609, Oja L 358,1, December 12, 1987; NIH Guide for the Care and Use of Laboratory Animals). All animals were 3-weekold males (C57/BL6 wild type and two FMR1 knockout strains on C57/BL6 and FVB background).
Western blots. We used standard methodologies with an FMRP monoclonal antibody (MAB2160) from Chemicon and a polyclonal antibody (rAM2) produced in our laboratory 8 . The PSD-95 antibody was from Upstate (1:1,000) and the eIF4E antibody from Cell Signaling (1:10,000). All secondary antibodies were from Promega. The proteins were revealed using ECL Plus and a phosphoimager (both from Amersham).
cDNA constructs. We obtained a mouse PSD-95 cDNA construct with the 3¢ UTR from the IMAGE consortium (ID 10318) and also isolated PSD-95 coding and 3¢ UTR fragments via RT-PCR from mouse brain extract and T/A cloning (Promega Easy T/A cloning kit; pT/A-Fragment 1-5). Details of constructs and mutagenesis are reported in the Supplementary Methods online. FMRP protein domains were previously reported 34 .
EMSA. We carried out binding reactions using full-length human FMRP protein in binding buffer (300 mM KCl, 5 mM MgCl 2 , 2 mM DTT, 0.5% glycerol, 20 mM HEPES pH 7.5 and 300 ng ml -1 tRNA), incubating at 25 1C or 4 1C for 30 min. We added heparin (0.3 mg) for 5 min before separation on a 6% native polyacrylamide gel. We carried out binding reactions with FMRP domains in the same buffer plus 100 or 300 mM KCl and 50-100-ng recombinant protein.
In vitro transcription. We carried out these reactions using standard protocols (Ambion SP6/T7 Mega-Script) with [a-32 P]UTP, [a- 35 S]UTP and UTP-Cy5 for EMSA, northern blotting and in situ hybridization, respectively. Primary cultures. We prepared primary cortical and hippocampal neuronal cultures from embryonic mice (embryonic day 15, cortical; embryonic day 19, hippocampal) using standard protocols.
Neuronal transfection. We transfected hippocampal neurons at 14 days in vitro (DIV) using a standard Ca 2+ phosphate precipitation protocol. We washed the precipitate using Hanks' balanced saline (HBSS) and carried out actinomycin D experiments 48 h later.
FISH, immunofluorescence and immunohistochemistry. We fixed primary hippocampal and cortical neurons at 20-25 1C for 15 min (4% paraformaldehyde, 2 mM MgCl 2 , 5 mM EGTA in 1Â PBS) and then UV irradiated and permeabilized the cells (1Â PBS containing 0.1% Triton X-100). We prehybridized neurons (50% formamide, 2Â SSC, 10 mM NaH 2 PO 3 ) and then hybridized at 42 1C (30% formamide, 10 mM NaH 2 PO 3 , 10% dextran sulfate, 2Â SSC, 0.2% BSA, 0.5 mg ml -1 yeast tRNA and 500 mg ml -1 salmon sperm DNA, and in vitro synthesized Cy5-labeled riboprobe). We carried out immunofluorescence and immunohistochemistry preincubation in 2% donkey serum, 0.2% Triton X-100, and then incubation in 1% BSA with antibodies specific for FMRP antibodies 8 , followed by Cy3-labeled secondary antibodies specific for rabbit IgG (Jackson ImmunoResearch). We analyzed neurons by confocal scanning microscopy (Zeiss LSM 510).
Radioactive in situ hybridization. We cryostat sectioned, fixed (4% paraformaldehyde), permeabilized (1 mg ml -1 proteinase K) and acetylated (0.25% of acetic anhydride in 0.1 M triethanolamine, pH 8.0) brains before prehybridization and hybridization using standard protocols (55 1C in 50% formamide, 1Â Denhardt's solution, 10% dextran sulfate, 0.3 M NaCl, 5 mM EDTA, 0.5 mg ml -1 yeast tRNA, 20 mM Tris HCl pH 8.0, 50 mM DTT and 10 5 cpm ml -1 of [a- 35 S]UTP-riboprobe). Slides were emulsified (Kodak autoradiography emulsion NTB2) and developed (ILFORD PQ developer) after 7-15 d of exposition. We analyzed sections by microscopy using a Zeiss Axioskop (1.25Â or 5Â objectives), acquired images with a Canon S50 digital camera and quantified the signal using ImageQuant and ImageJ.
Immunoprecipitation and RT-PCR. Whole brain was homogenized in 10 mM HEPES pH 7.4, 200 mM NaCl, 0.5% Triton X-100, 30 mM EDTA, protease inhibitors (Sigma-Aldrich) and 30 U ml -1 RNasin. We preblocked 20 ml protein A-Sepharose (0.1 mg ml -1 BSA, 0.1 mg ml -1 yeast tRNA and 0.1 mg ml -1 glycogen) for 1 h and then immunoprecipitated with specific FMRP antibodies 8 . DNase I (RNase-free, Amersham Pharmacia Biotech) was added during washes. We treated the immunoprecipitate with 50 mg proteinase K (Sigma-Aldrich) before RNA extraction and precipitation. First-strand synthesis was performed using p(dN)6 and 100 U of M-MLV RTase (Invitrogen). RT-PCR was performed as described in ref. 8 . Radioactive semiquantitative RT-PCR reactions were performed in nonsaturating conditions in the presence of 0.2 m Ci [a-32 P]dCTP, 1 mM dCTP and 10 mM each dATP, dGTP and dTTP and analyzed on a 5% polyacrylamide gel.
Reversible cross-linking. We performed experiments as previously described 32 . Briefly, we washed hippocampal neurons at 10 DIV with Neurobasal medium containing 2% B27, and cross-linked them in 0.5% formaldehyde (J.T. Baker) for 30 min at 20-25 1C and quenched with 0.25 M glycine (Bio-Rad). We harvested cells by centrifugation, PBS washing and resuspension in RIPA buffer (see ref. 32 ). We immunoprecipitated cross-linked complexes with an FMRP antibody 8 . Before RT-PCR, we reversed cross-linking by treatment at 70 1C.
Polysomal analysis and RT-PCR. We analyzed cytoplasmic brain extract (of total brain and hippocampi) as previously described 8 . See Supplementary Methods for details. mRNA stability assay. We treated primary cortical or hippocampal cultures (10 DIV) from time 0 with actinomycin D (10 mg ml -1 ) for the indicated times. We washed cultures in PBS, extracted RNA with Trizol and analyzed RNA by quantitative RT-PCR. We used a NIKON C1 with plan-neofluar 20Â to analyze both wild-type and FMR1 knockout cultures for morphology. We assessed mRNA stability after DHPG treatment in two different ways. First, we added DHPG (100 mM) to cultures pre-exposed to actinomycin D for 3.5 h or 5.5 h. After 30 min of DHPG treatment, we collected mRNA for quantitative RT-PCR analysis. Second, we added DHPG (50 mM) and actinomycin D jointly to cells at time 0 and collected RNA 4 or 6 h later for quantitative RT-PCR analysis.
Quantitative RT-PCR. We carried out reactions with MoMLV-reverse transcriptase (Invitrogen) and the TaqMan Universal PCR Master Mix (ABI 4304437) using dual-labeled TaqMan probes (Applied Biosystems). We detected mouse PSD-95 mRNA using the Pre-Developed TaqMan probe Mm00492193_m1 and compared with the endogenous control mRNA (mouse H3f3b mRNA Pre-Developed TaqMan probe Mm00787223_s1). Cycle parameters were as suggested by the manufacturer. Relative PSD-95 mRNA levels, normalized to H3f3b, were calculated as follows: 2 -[DeltaCt(treated) -DeltaCt(untreated)] ¼ 2 -DeltaCt , where DeltaCt equals Ct(PSD-95) -Ct(H3f3b). b-actin mRNA was detected with Pre-Developed TaqMan probe
